RYTM - Rhythm Pharmaceuticals, Inc

Healthcare - Sector
Coverage Rating Distribution Performance Price Targets & Ratings Chart

RYTM is currently covered by 8 analysts with average potential upside of $7.35 (85.17%) backed by 30 price targets and 52 ratings. Documented since 30-Oct-2017. Analyst's average stock valuation to be materialised ratio is 71.46% with an average time for price targets to be met of 209.89 days.

Most recent stock forecast was given by JEFFREY HUNG from MORGAN STANLEY on 02-Mar-2023.

Highest price target for RYTM is 26, Lowest price target is 3, average price target is 14.5.

Currently, out of the existing stock ratings of RYTM - 14 which are a Buy (48.28%), 14 which are a Hold (48.28%), 1 which are a Sell (3.45%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

28

$10.89 (63.65%)

26

26 days ago

4/7 (57.14%)

$1.55 (8.78%)

75

Buy

45

$27.89 (163.00%)

35

26 days ago

6/9 (66.67%)

$5.13 (30.65%)

90

Buy

32

$14.89 (87.03%)

42

26 days ago

2/4 (50%)

$6.8 (24.63%)

522

Buy

35

$17.89 (104.56%)

23

26 days ago

3/7 (42.86%)

$13.38 (82.14%)

120

Sell

20

$2.89 (16.89%)

17

7 months 23 days ago

4/5 (80%)

$1.68 (8.78%)

122

Show more analysts

What is RYTM(Rhythm Pharmaceuticals, Inc) average time for price targets to be met?

On average it took 209.89 days on average for the stock forecasts to be realized with a an average price target met ratio 71.46

Which analyst has the current highest performing score on RYTM(Rhythm Pharmaceuticals, Inc) with a proven track record?

MICHAEL HIGGINS